Eli Lilly shares slip 7% premarket as weight-loss pill study overshadows earnings
Go back to Eli Lilly shares slip 7% premarket as weight-loss pill study overshadows earnings| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1164.89 +11.96 (1.04%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1152.93 | 52 Week High | $88.16 | |||
| Open | $1144.49 | 52 Week Low | $67.88 | |||
| Day High | $1170.90 | P/E | 269.65 | |||
| Day Low | $1134.41 | EPS | $4.32 | |||
| Volume | 2,479,448 | |||||
| NOVO-NORDISK A/S (NYSE: NVO) | Delayed: 39.80 -3.44 (7.96%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $43.24 | 52 Week High | $59.00 | |||
| Open | $41.05 | 52 Week Low | $32.80 | |||
| Day High | $41.17 | P/E | N/A | |||
| Day Low | $39.54 | EPS | $0.00 | |||
| Volume | 49,355,679 | |||||
